Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - oral solution/suspension - trimethoprim pyrimidine active 80.0 g/l; sulfadiazine sulfanyl active 400.0 g/l - antibiotic & related - pigs | poultry | turkeys | boar | breeder | breeders | broiler | broiler breeder | chickens | chicks | chooks | day old chicks | - bacterial infection | diarrhoea | escherichia coli (e. coli) | haemophilus spp. | pasteurella spp. | salmonella | staphylococci | absorptive | acute diarrhoea | acute intestinal catarrh | amoxycillin sensitive bacteria | associated with viral disease | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | gram negative organisms | gram positive organisms | growth rate | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | including b-lactamase producin | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | pasterellosis | pasteurellosis | poisoning | post parturient bacterial infe | postweaning scours | primary bacterial infection | prophylactic | salmonellosis | scours | streptomycin sensitive bacteri | sulfadiazine se

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 80.0 mg/ml; sulfadiazine sulfanyl active 400.0 mg/ml - antibiotic & related - cattle | horse | pigs | sheep ewe - dry | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | co - bacterial infection | infections of the alimentary tract | infections of the respiratory tract | infections of the urogenital tract | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | cystitis | gram negative organisms | gram positive organisms | metritis | nephritis | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Estats Units - anglès - NLM (National Library of Medicine)

redpharm drug, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv) - trimethoprim 160 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets, usp and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute otitis m

Estats Units - anglès - NLM (National Library of Medicine)

akorn - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim 1 mg in 1 ml - polymyxin b sulfate and trimethoprim ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa. * *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

Estats Units - anglès - NLM (National Library of Medicine)

actavis pharma, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg

Estats Units - anglès - NLM (National Library of Medicine)

avpak - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg

Estats Units - anglès - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - trimethoprim - oral tablet - 100mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - trimethoprim - oral tablet - 100mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - trimethoprim - oral tablet - 100mg